PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death

British Journal of Cancer

Volumn 92, Issue 4, 2005, Pages 705-710

  Hotfilder, M ^a   Sondermann, P ^a   Senss A ^a   Van Valen, F ^b   Jurgens H ^a   Vormoor, J ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Department of Orthopedics ^*  (Germany)

Author keywords

Apoptosis; Basic fibroblast growth factor; Ewing tumours; Fibroblast growth factor 2; Survival signals

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; INTEGRIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; AKT1 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE;

ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; EWING SARCOMA; HUMAN; HUMAN CELL; MONOLAYER CULTURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; BONE TUMOR; CELL DEATH; METABOLISM; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BONE NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; FIBROBLAST GROWTH FACTOR 2; HUMANS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SARCOMA, EWING'S; SIGNAL TRANSDUCTION;

EID: 14944381154     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602384     Document Type: Article

References (32)

1. Aoudjit F, Vuori K (2001) Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells. Oncogene 20: 4995-5004
2. Arvand A, Denny CT (2001) Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20: 5747-5754
3. Bisping G, Leo R, Wenning D, Dankbar B, Padro T, Kropff M, Scheffold C, Kroger M, Mesters RM, Berdel WE, Kienast J (2003) Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma. Blood 101: 2775-2783, doi:10.1182/blood-2002-09-2907
4. Brunner G, Nguyen H, Gabrilove J, Rifkin DB, Wilson EL (1993) Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 81: 631-638
5. Collin-Osdoby P, Rothe L, Bekker S, Anderson F, Huang Y, Osdoby P (2002) Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro. J Bone Miner Res 17: 1859-1871
6. Danen EHJ, Yamada KM (2001) Fibronectin, integrins, and growth control. J Cell Physiol 189: 1-13
7. Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927
8. De Alava E, Gerald WL (2000) Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family. J Clin Oncol 18: 204-213
9. Engling A, Backhaus R, Stegmayer C, Zehe C, Seelenmeyer C, Kehlenbach A, Schwappach B, Wegehingel S, Nickel W (2002) Biosynthetic FGF-2 is targeted to non-lipid raft microdomains following translocation to the extracellular surface of CHO cells. J Cell Sci 115: 3619-3631, doi:10.1242/jcs.00036
10. Girnita L, Girnita A, Wang M, Meis-Kindblom JM, Kindblom L-G, Larsson O (2000) A link between basic fibroblast growth factor (bFGF) and EWS/FLI1 in Ewing's sarcoma cells. Oncogene 19: 4298-4301
11. Hansen MB, Nielsen SE, Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119: 203-210
12. Hotfilder M, Lanvers C, Jurgens H, Boos J, Vormoor J (2002) c-KIT-expressing Ewing tumour cells are insensitive to imatinib mesylate (STI571). Cancer Chemother Pharmacol 50: 167-169, doi:10.1007/s00280-002-0477-8
13. Kim M-S, Kim CJ, Jung HS, Seo MR, Juhnn Y-S, Shin HY, Ahn HS, Thile CJ, Chi JG (2004) Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells. J Pathol 202: 103-112
14. Knoop LL, Baker SJ (2001) EWS/FLI alters 5′-splice site selection. J Biol Chem 276: 22317-22322, doi:10.1074/jbc.M008950200
15. Lawlor ER, Scheel C, Irving J, Sorensen PH (2002) Anchorage-independent multi-cellular shperoids as an in vitro model of growth signaling in Ewing tumors. Oncogene 21: 307-318, doi:10.1038/sj.onc.1205053
16. Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411: 375-379
17. Neufeld G, Mitchell R, Ponte P, Gospodarowicz D (1988) Expression of human basic fibroblast growth factor cDNA in baby hamster kidney-derived cells results in autonomous cell growth. J Cell Biol 106: 1385-1394
18. Ornitz DM, Itoh N (2001) Fibroblast growth factors. Genome Biol 2, reviews 3005.1-3005.12
19. Santini MT, Rainaldi G (1999) Three-dimensional spheroid model in tumor biology. Pathobiology 67: 148-157, doi:10.1159/000028065
20. Schweigerer L, Neufeld G, Gospodarowicz D (1987) Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells. J Clin Invest 80: 1516-1520
21. Scotlandi K, Avnet S, Benini S, Manara MC, Serra M, Cerisano V, Perdichizzi S, Lollini PL, De Giovanni C, Landuzzi L, Picci P (2002) Expression of an IGF-1 receptor dominant negative mutant induces apoptosis, inhibits tunorigenesis and enhances chemosensitivity in Ewing's sarcoma cells. Int J Cancer 101: 11-16, doi 10.1002/ijc.10537
22. Scotlandi K, Benini S, Sarti M, Serra M, Lollini PL, Maurici D, Picci P, Manara MC, Baldini N (1996) Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target. Cancer Res 56: 4570-4574
23. Sturla L-M, Westwood G, Selby PJ, Lewis IJ, Burchill SA (2000) Induction of cell death by basic fibroblast growth factor in Ewings's sarcoma. Cancer Res 60: 6160-6170
24. Toretsky JA, Thakar M, Eskenazi AE, Frantz CN (1999) Phosphoinositide 3-hydroxide kinase blockade enhances apoptosis in the Ewing's sarcoma family of tumors. Cancer Res 59: 5745-5750
25. van Valen F (1999) Ewing's sarcoma family of tumors. In Human Cell Culture vol I, Masters JRW and Palsson B (eds) pp 55-85. London: Kluwer Academic Publisher
26. van Valen F, Winkelmann W, Jürgens H (1992) Type I and type II insulin-like growth factor receptors and their function in human Ewing's sarcoma cells. J Cancer Res Clin Oncol 118: 269-275
27. Vlahos CJ, Matter WF, Hui KY, Brown RF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248
28. Vormoor J, Baersch G, Decker S, Hotfilder M, Schafer KL, Pelken L, Rube C, van Valen F, Jürgens H, Dockhorn-Dworniczak B (2001) Establishment of an in vivo model for pediatric ewing tumors by transplantation into NOD/scid mice. Pediatr Res 49: 332-341
29. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, Williams RL (2000) Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6: 909-919
30. Westwood G, Dibling BC, Cuthbert-Heavens D, Burchill SA (2002) Basic fibroblast growth factor (bFGF)-induced cell death is mediated through a caspase-dependent and p53-independent cell death receptor pathway. Oncogene 21: 809-824, doi 10.1038/sj.onc.1205128
31. Whang-Peng J, Triche TJ, Knutsen T, Miser J, Douglass EC, Israel MA (1984) Chromosome translocation in peripheral neuroepithelioma. N Engl J Med 311: 584-585
32. Zhang X, Sobue T, Hurley MM (2002) FGF-2 increases colony formation, PTH receptor, and IGF-1 mRNA in mouse marrow stromal cells. Biochem Biophys Res Commun 290: 526-531, doi:1006/bbrc.2001.6217